SCHEMBL30490586

SCHEMBL30490586

CCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CCN)NC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ IL23R Q5VWK5 10/20 0.50
▸ KISS1R Q969F8 3/20 0.49
▸ NPY4R P50391 3/20 0.49
▸ NPY1R P25929 2/20 0.49
▸ NPY2R P49146 2/20 0.49
▸ NPY5R Q15761 2/20 0.49
▸ VIPR2 P41587 4/20 0.48
▸ VIPR1 P32241 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30490602 1.00 IL23R (0.50) IL23RKISS1RNPY4RNPY1RNPY2R
SCHEMBL29415058 1.00 IL23R (0.50) IL23RKISS1RNPY4RNPY1RNPY2R
SCHEMBL30490599 0.98 KISS1R (0.51) IL23RKISS1RNPY4RNPY1RNPY2R
SCHEMBL30490567 0.97 IL23R (0.54) IL23RVIPR2VIPR1
SCHEMBL30490579 0.97 IL23R (0.52) IL23RKISS1RNPY4RNPY1RNPY2R
SCHEMBL30490566 0.97 IL23R (0.52) IL23RKISS1RNPY4RNPY1RNPY2R
SCHEMBL30490562 0.96 NPY4R (0.55) IL23RKISS1RNPY4RNPY1RNPY2R
SCHEMBL30490580 0.96 NPY4R (0.55) IL23RKISS1RNPY4RNPY1RNPY2R
SCHEMBL30490583 0.95 IL23R (0.51) IL23RKISS1RVIPR2VIPR1
SCHEMBL30490589 0.95 IL23R (0.51) IL23RKISS1RVIPR2VIPR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4214221-A1 ANTIMICROBIAL PEPTIDOMIMETICS Spexis AG (CH) 2023-07-26 — — EP claimed
EP-4214221-A1 ANTIMICROBIAL PEPTIDOMIMETICS Spexis AG (CH) 2023-07-26 — — EP disclosed
Send feedback